Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
The FDA now allows most new drugs to be approved based on just one clinical trial to speed up access and lower costs.
The FDA has revised its drug approval process, allowing most new drugs to be approved based on a single clinical trial instead of the traditional two, citing advances in science and data analysis.
The change, effective immediately, aims to speed up access to treatments, reduce development costs, and lower drug prices, particularly for rare and serious conditions.
While the agency maintains strong safety standards and can still require additional studies post-approval, experts remain divided on whether the shift improves efficiency or risks patient safety.
4 Articles
La FDA ahora permite que la mayoría de los nuevos fármacos sean aprobados basándose en un solo ensayo clínico para acelerar el acceso y reducir los costos.